Abbott Laboratories ROA 2006-2019 | ABT

Current and historical return on assets (ROA) values for Abbott Laboratories (ABT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Abbott Laboratories ROA for the three months ending June 30, 2019 was 7.83%.
Abbott Laboratories ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-06-30 $2.90B $68.43B 4.21%
2019-03-31 $2.62B $67.61B 3.82%
2018-12-31 $2.37B $67.17B 3.41%
2018-09-30 $0.89B $71.64B 1.23%
2018-06-30 $0.93B $68.42B 1.29%
2018-03-31 $0.48B $70.91B 0.66%
2017-12-31 $0.48B $76.25B 0.66%
2017-09-30 $2.10B $72.25B 3.15%
2017-06-30 $1.17B $71.15B 2.00%
2017-03-31 $1.50B $70.89B 2.96%
2016-12-31 $1.40B $52.67B 3.26%
2016-09-30 $1.37B $39.50B 3.42%
2016-06-30 $2.28B $39.83B 5.61%
2016-03-31 $2.45B $39.64B 5.87%
2015-12-31 $4.42B $41.25B 10.40%
2015-09-30 $4.56B $41.73B 10.72%
2015-06-30 $4.52B $44.13B 10.57%
2015-03-31 $4.20B $43.10B 9.99%
2014-12-31 $2.28B $41.21B 5.48%
2014-09-30 $1.97B $42.51B 4.67%
2014-06-30 $2.40B $41.48B 5.63%
2014-03-31 $2.41B $41.66B 5.61%
2013-12-31 $2.58B $42.95B 5.97%
2013-09-30 $3.04B $44.13B 6.17%
2013-06-30 $4.02B $42.90B 7.43%
2013-03-31 $5.27B $42.69B 8.96%
2012-12-31 $5.96B $67.24B 9.36%
2012-09-30 $6.53B $63.26B 10.54%
2012-06-30 $4.89B $61.86B 8.01%
2012-03-31 $5.11B $62.42B 8.36%
2011-12-31 $4.73B $60.28B 7.77%
2011-09-30 $4.55B $59.63B 7.47%
2011-06-30 $5.14B $62.00B 8.51%
2011-03-31 $4.49B $61.65B 7.71%
2010-12-31 $4.63B $60.57B 8.24%
2010-09-30 $4.73B $57.37B 8.72%
2010-06-30 $5.31B $53.38B 10.16%
2010-03-31 $5.31B $53.36B 10.44%
2009-12-31 $5.75B $52.58B 11.76%
2009-09-30 $5.74B $49.85B 12.39%
2009-06-30 $5.35B $47.63B 12.07%
2009-03-31 $5.38B $45.44B 12.39%
2008-12-31 $4.88B $42.42B 11.52%
2008-09-30 $4.55B $41.75B 10.91%
2008-06-30 $4.18B $44.07B 10.28%
2008-03-31 $3.85B $41.18B 9.89%
2007-12-31 $3.61B $39.71B 9.57%
2007-09-30 $1.93B $37.62B 5.24%
2007-06-30 $1.93B $37.15B 5.39%
2007-03-31 $1.55B $36.29B 4.43%
2006-12-31 $1.72B $36.18B 5.20%
2006-09-30 $3.17B $33.30B 10.14%
2006-06-30 $3.13B $34.06B 10.40%
2006-03-31 $3.40B $28.53B 11.89%
2005-12-31 $3.37B $29.14B 11.76%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $149.840B $30.578B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $137.817B 19.69
Stryker (SYK) United States $81.180B 28.07
Boston Scientific (BSX) United States $58.714B 28.48
Baxter (BAX) United States $44.403B 26.93
EssilorLuxottica Societe Anonyme (ESLOY) France $30.829B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.130B 18.00
Coloplast (CLPBY) Denmark $26.395B 42.14
Lonza Group Ag (LZAGY) Switzerland $26.038B 0.00
Terumo (TRUMY) Japan $23.788B 27.35
Smith & Nephew SNATS (SNN) United Kingdom $20.267B 0.00
ResMed (RMD) United States $19.315B 36.83
Sunny Optical Technology (SNPTF) China $13.689B 0.00
Bio-Rad Laboratories (BIO) United States $9.759B 52.32
Canopy Growth (CGC) Canada $9.745B 0.00
Insulet (PODD) United States $9.055B 536.57
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Haemonetics (HAE) United States $7.033B 53.07
Hill-Rom Holdings (HRC) United States $7.032B 20.97
Perrigo (PRGO) Ireland $6.283B 11.57
Aurora Cannabis (ACB) Canada $6.094B 59.90
GN STORE NORD (GNNDY) Denmark $5.897B 30.11
GW Pharmaceuticals (GWPH) United Kingdom $4.651B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.710B 61.70
ICU Medical (ICUI) United States $3.430B 22.25
NuVasive (NUVA) United States $3.316B 26.44
Hutchison China MediTech (HCM) China $2.737B 0.00
Quidel (QDEL) United States $2.552B 25.34
Agios Pharmaceuticals (AGIO) United States $2.491B 0.00
National Vision Holdings (EYE) United States $2.177B 46.98
Cardiovascular Systems (CSII) United States $1.682B 0.00
Aphria (APHA) $1.551B 0.00
Phibro Animal Health (PAHC) United States $1.263B 18.92
AtriCure (ATRC) United States $1.060B 0.00
VAREX IMAGING (VREX) United States $1.018B 23.45
NanoString Technologies (NSTG) United States $0.977B 0.00
Omeros (OMER) United States $0.967B 0.00
PetIQ (PETQ) United States $0.908B 21.44
Lantheus Holdings (LNTH) United States $0.897B 23.57
Eagle Pharmaceuticals (EGRX) United States $0.794B 20.23
Cerus (CERS) United States $0.769B 0.00
MacroGenics (MGNX) United States $0.737B 0.00
Quanterix (QTRX) United States $0.702B 0.00
TG Therapeutics (TGTX) United States $0.648B 0.00
LeMaitre Vascular (LMAT) United States $0.626B 37.08
Surmodics (SRDX) United States $0.601B 114.26
OraSure Technologies (OSUR) United States $0.446B 20.63
Meridian Bioscience (VIVO) United States $0.432B 13.48
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.423B 0.00
BioLife Solutions (BLFS) United States $0.376B 123.63
United Health Products (UEEC) United States $0.350B 0.00
Utah Medical Products (UTMD) United States $0.349B 25.56
Zynex (ZYXI) United States $0.345B 36.62
Owens & Minor (OMI) United States $0.306B 9.17
Bovie Medical (APYX) United States $0.251B 0.00
Vapotherm (VAPO) United States $0.244B 0.00
Cytosorbents (CTSO) United States $0.155B 0.00
Chimerix (CMRX) United States $0.153B 0.00
Fonar (FONR) United States $0.152B 8.01
Rockwell Medical (RMTI) United States $0.152B 0.00
Female Health (VERU) United States $0.123B 0.00
InfuSystems Holdings (INFU) United States $0.099B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
United-Guardian (UG) United States $0.087B 20.65
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Surface Oncology (SURF) United States $0.055B 0.00
Nephros (NEPH) United States $0.054B 0.00
MRI INTERVENTNS (MRIC) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Trinity Biotech (TRIB) Ireland $0.041B 14.17
Senestech (SNES) United States $0.039B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Myomo (MYO) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00